Gavin Bennet

Gavin Bennet

Company: Bicycle Therapeutics

Job title: Head of Pre-Clinical Development

Seminars:

Chair’s Closing Remarks 5:30 pm

Read more

day: Day Two

Bicycle Conjugates to Target Solid Tumors 8:40 am

Bicycles, constrained bicyclic peptides, offer antibody-like affinity and selectivity in a small molecule format Bicycle Toxin Conjugates are now in clinical development, offering rapid tumor penetration with limited plasma exposure Discover how Bicycles can be used to stimulate Immuno-oncology targets such as CD137, which can be targeted to tumor cells using Bicycle tumor-targeted immune cell…Read more

day: Day One

Chair’s Opening Remarks 8:30 am

Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.